These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36246181)

  • 1. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS; Allingham MJ; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.
    Khanani AM; Maturi RK; Bagheri N; Bakall B; Boyer DS; Couvillion SS; Dhoot DS; Holekamp NM; Jamal KN; Marcus DM; Pieramici D; Aziz AA; Patki KC; Bridges WZ; Barone SB
    Ophthalmol Sci; 2022 Jun; 2(2):100154. PubMed ID: 36249705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
    Heier JS; Ho AC; Samuel MA; Chang T; Riemann CD; Kitchens JW; Slakter JS; Leiderman YI; Spencer R; Williams GA; Hickson-Curran SB; Keane M; Baldassarre JS;
    Ophthalmol Retina; 2020 Apr; 4(4):384-393. PubMed ID: 32033908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
    Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural Biomarkers.
    Künzel SH; Lindner M; Sassen J; Möller PT; Goerdt L; Schmid M; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Pfau M
    JAMA Ophthalmol; 2021 Nov; 139(11):1191-1199. PubMed ID: 34591067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).
    Lek JJ; Brassington KH; Luu CD; Chen FK; Arnold JJ; Heriot WJ; Durkin SR; Chakravarthy U; Guymer RH;
    Ophthalmol Retina; 2017; 1(3):227-239. PubMed ID: 31047426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration.
    Heier JS; Cohen MN; Chao DL; Pepio A; Shiraga Y; Capuano G; Rogers A; Ackert J; Sen HN; Csaky K
    Ophthalmology; 2024 Jun; ():. PubMed ID: 38909914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Low Luminance Questionnaire With Objective Functional Measures in Early and Intermediate Age-Related Macular Degeneration.
    Thompson AC; Luhmann UFO; Stinnett SS; Vajzovic L; Horne A; Toth CA; Cousins SW; Lad EM
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):289-297. PubMed ID: 29340643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Cataract Surgery on Low Luminance Visual Acuity Deficit Measurements.
    Shen M; Shi Y; Wang L; Russell JF; Jiang X; Laiginhas R; Iyer P; Trivizki O; Thulliez M; Yoo SH; Rose TP; Habash RG; Amescua G; Feuer WJ; Gregori G; Rosenfeld PJ
    Ophthalmol Sci; 2022 Sep; 2(3):100170. PubMed ID: 36245760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
    Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
    Jaffe GJ; Westby K; Csaky KG; Monés J; Pearlman JA; Patel SS; Joondeph BC; Randolph J; Masonson H; Rezaei KA
    Ophthalmology; 2021 Apr; 128(4):576-586. PubMed ID: 32882310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.
    Lad EM; Fang V; Tessier M; Rautanen A; Gayan J; Stinnett SS; Luhmann UFO
    Ophthalmol Sci; 2022 Sep; 2(3):100173. PubMed ID: 36245764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Geographic Atrophy Using Spectral Domain OCT in Age-Related Macular Degeneration.
    Cleland SC; Konda SM; Danis RP; Huang Y; Myers DJ; Blodi BA; Domalpally A
    Ophthalmol Retina; 2021 Jan; 5(1):41-48. PubMed ID: 32679202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration.
    Querques L; Querques G; Forte R; Souied EH
    Am J Ophthalmol; 2012 Jun; 153(6):1110-5. PubMed ID: 22321805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS; Pieramici D; Chakravarthy U; Patel SS; Gupta S; Lotery A; Lad EM; Silverman D; Henry EC; Anderesi M; Tschosik EA; Gray S; Ferrara D; Guymer R;
    Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits.
    Grewal MK; Chandra S; Gurudas S; Bird A; Jeffery G; Sivaprasad S
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32882940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.
    Sayegh RG; Simader C; Scheschy U; Montuoro A; Kiss C; Sacu S; Kreil DP; Prünte C; Schmidt-Erfurth U
    Ophthalmology; 2011 Sep; 118(9):1844-51. PubMed ID: 21496928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
    ; Huynh N; Nicholson BP; Agrón E; Clemons TE; Bressler SB; Rosenfeld PJ; Chew EY
    Ophthalmology; 2014 Jun; 121(6):1229-36. PubMed ID: 24613825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.